Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurens P Bosman

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Heart (British Cardiac Society)|May 15, 2021
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratificationLaurens P Bosman, Anneline S J M Te Riele
Expert Review of Cardiovascular Therapy|August 20, 2019
Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an updateJulia Cadrin-Tourigny, Laurens P Bosman, Rafik Tadros, et al.
Physiological Measurement|January 19, 2017
Non-invasive measurement of volume-time curves in patients with mitral regurgitation and in healthy volunteers, using a new operator-independent screening toolMaurits K Konings, Rosemarijn Jansen, Laurens P Bosman, et al.
Circulation. Genomic and Precision Medicine|May 17, 2022
Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-AnalysisApurva Sharma, Laurens P Bosman, Crystal Tichnell, et al.
The Lancet. Haematology|March 6, 2020
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysisMarijke Linschoten, Janine A M Kamphuis, Anna van Rhenen, et al.
ESC Heart Failure|July 17, 2022
Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysisMark Jansen, Sila Algül, Laurens P Bosman, et al.
Echocardiography (Mount Kisco, N.Y.)|May 4, 2020
Development of an algorithm for automatic classification of right ventricle deformation patterns in arrhythmogenic right ventricular cardiomyopathyMarijn H A Groen, Laurens P Bosman, Arco J Teske, et al.
Heart Rhythm|February 7, 2018
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysisLaurens P Bosman, Arjan Sammani, Cynthia A James, et al.
Heart Rhythm|June 10, 2022
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathyRemco de Brouwer, Laurens P Bosman, Sophia Gripenstedt, et al.
ESC Heart Failure|April 15, 2020
Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic reviewArjan Sammani, Elham Kayvanpour, Laurens P Bosman, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Heart (British Cardiac Society)|May 15, 2021
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratificationLaurens P Bosman, Anneline S J M Te Riele
Expert Review of Cardiovascular Therapy|August 20, 2019
Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an updateJulia Cadrin-Tourigny, Laurens P Bosman, Rafik Tadros, et al.
Physiological Measurement|January 19, 2017
Non-invasive measurement of volume-time curves in patients with mitral regurgitation and in healthy volunteers, using a new operator-independent screening toolMaurits K Konings, Rosemarijn Jansen, Laurens P Bosman, et al.
Circulation. Genomic and Precision Medicine|May 17, 2022
Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-AnalysisApurva Sharma, Laurens P Bosman, Crystal Tichnell, et al.
The Lancet. Haematology|March 6, 2020
Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysisMarijke Linschoten, Janine A M Kamphuis, Anna van Rhenen, et al.
ESC Heart Failure|July 17, 2022
Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysisMark Jansen, Sila Algül, Laurens P Bosman, et al.
Echocardiography (Mount Kisco, N.Y.)|May 4, 2020
Development of an algorithm for automatic classification of right ventricle deformation patterns in arrhythmogenic right ventricular cardiomyopathyMarijn H A Groen, Laurens P Bosman, Arco J Teske, et al.
Heart Rhythm|February 7, 2018
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysisLaurens P Bosman, Arjan Sammani, Cynthia A James, et al.
Heart Rhythm|June 10, 2022
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathyRemco de Brouwer, Laurens P Bosman, Sophia Gripenstedt, et al.
ESC Heart Failure|April 15, 2020
Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic reviewArjan Sammani, Elham Kayvanpour, Laurens P Bosman, et al.
Pageof 4